AbbVie (ABBV) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ABBV AbbVie

Watchlist

186.540
-2.320-1.23%

Close Oct 21 16:00 ET

187.130
+0.590+0.32%

Pre 06:56 ET

329.49BMarket Cap62.39P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

The Zacks Analyst Blog Highlights Johnson & Johnson, Pfizer, Roche, AbbVie and Sanofi
Zacks 04:00 ET
AbbVie Falters Despite Progress in Lymphoma Treatment
Baystreet.caOct 21 10:18 ET
Goldman Sachs Adjusts Price Target on AbbVie to $208 From $200
MT NewswiresOct 21 08:19 ET · Ratings
AbbVie Announces That 9 Canadian Provinces Have Provided Accelerated Public Coverage Of EPKINLY, A Treatment For Adult Patients With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma
BenzingaOct 21 08:14 ET
Express News | Nine Provinces Approve Accelerated Public Reimbursement of Diffuse Large B-Cell Lymphoma Treatment Under New Early Access Process
ReutersOct 21 08:00 ET
Express News | Convatec Collaborates With Abbvie for Vyalev Therapy for Treatment of Advanced Parkinson’s Disease in United States
ReutersOct 21 03:02 ET

Comments

Bellaah

Oct 9 14:05

$AbbVie (ABBV.US)$ 200

Moomoo News Global

Sep 19 07:24

Columns Will Rate Cuts Boost the Stock Market? A Global Equity Investment Guide

The Federal Reserve on Wednesday implemented its first rate cut in over four years, reducing the benchmark rate by 50 basis points to a range of 4.75%-5%.
The move surpassed Wall Street's expectations. Analysts had generally anticipated a 25 basis point cut, while the futures market had priced in a 61% probability of a 50 basis point cut and a 39% probability of a 25 basis point reduction.
Market Response to First Rate Cut
St...

Fed officials hawkish: Will inflation roil U.S. bonds?

In One Chart

Aug 22 07:58

Columns In One Chart | Wall Street Eyes New Sectors for the Next Stock Market Surge

Recent data shows that defensive sectors like utilities, consumer defensive, and healthcare have outperformed the information technology sector over the past month, reaching 52-week highs.
Notably, several stocks within these sectors have shown exceptional performance. Pharmaceutical giants with market values in the hundreds of billions, such as $Eli Lilly and Co (LLY.US)$, $Thermo Fisher Scientific (TMO.US)$, $AbbVie (ABBV.US)$, and ...